Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642212 · ClinicalTrials.gov registry record · Phase 2
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
A Phase 2 study of Eosinophilic Esophagitis (EoE), sponsored by Shire.
- Completed
- Registry status
- Phase 2
- Development phase
- 93
- Enrollment target
- 20
- Study locations
NCT01642212 is a Phase 2 study of Eosinophilic Esophagitis (EoE) that has completed, run by Shire. The registered enrollment target is 93 participants, below the 117-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (21% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT01642212, a Phase 2 study of Eosinophilic Esophagitis (EoE), has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 93 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a clinical trial to test an experimental drug for the treatment of Eosinophilic Esophagitis (EoE)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oral Budesonide Suspension (MB-9)
Study Locations (20)
Illinois
- Northwestern Scool of Medicine - Chicago
- Children's Memorial Hospital - Chicago
- Center for Children's Digestive Health - Park Ridge
California
- Children's Hospital of Orange County - Orange
- UCSD Rady Children's Hospital - San Diego
Indiana
- Indiana University Health University Hospital - Indianapolis
- Riley Hospital for Children - Indianapolis
Massachusetts
- Tufts Medical Center - Boston
- Children's Hospital Boston - Boston
Ohio
- The Cincinnati Center for Eosinophilic Disorders - Cincinnati
- Great Lakes Gastroenterology - Mentor
Arizona
- Phoenix Children's Hospital - Phoenix
Colorado
- The Children's Hospital - Aurora
Georgia
- Children's Center for Digestive Healthcare - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2012-07-23 |
| Est. Completion | 2014-10-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01642212
The ClinicalTrials.gov registry entry for NCT01642212 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (21% lower). The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eosinophilic Esophagitis (EoE) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01642212 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Illinois, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT01642212 about?
NCT01642212 is a clinical study titled "OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension". This is a clinical trial to test an experimental drug for the treatment of Eosinophilic Esophagitis (EoE)
What is the current status of trial NCT01642212?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 93 participants. The study started on 2012-07-23. Estimated completion is 2014-10-30.
What conditions does trial NCT01642212 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis (EoE).
What interventions are being tested in trial NCT01642212?
The interventions under investigation include: Placebo (DRUG), Oral Budesonide Suspension (MB-9) (DRUG).
Who is sponsoring clinical trial NCT01642212?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01642212 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis (EoE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
ACTIVE NOT RECRUITING · Phase 2
-
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
COMPLETED · Phase 2
-
Surface EMG Testing on Swallowing in EoE Patients
RECRUITING
-
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
RECRUITING
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
RECRUITING · Phase 4
-
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.